Mounjaro®
Starting from £179.99/mo
Start journey Learn morePaying privately for Wegovy in the UK typically means spending somewhere between £150 and £375 per month, depending on your dose and the provider you choose. That range has widened since Eli Lilly's September 2025 list-price increase — though semaglutide pricing at private clinics moves independently. Any legitimate private price covers a prescription issued after proper clinical assessment; Wegovy is a prescription-only medicine, so no reputable pharmacy can supply it without one. If you've spent the last half-hour trying to work out whether the numbers you're seeing online actually mean what they say, you're not alone — and the rest of this page exists to make that clearer.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Imagine this: you've searched, found a headline figure for Wegovy, and it looks affordable. Then, at checkout, a consultation fee appears. Or a prescription charge. Or a delivery cost that somehow wasn't mentioned. This is a pattern worth knowing about before you commit anywhere.
Private Wegovy prices in the UK are quoted per pen, and each pen typically covers four weeks of injections at a single dose. So the monthly cost you pay depends on which dose your prescriber decides is right for you, and that changes as treatment progresses. The starting dose is low, primarily to let your body adjust; the doses that tend to deliver the most meaningful results sit higher up the schedule, and those pens carry higher price tags.
Some providers quote only the medicine cost, then add a separate fee for the initial consultation, a renewal fee each time you want another pen, and a delivery charge on top. Others bundle everything. Understanding the full monthly cost of private Wegovy means asking one simple question: what exactly does this price include before the pen is in my hands? The practical side of paying privately for Wegovy involves more variables than the headline figure suggests, which is why transparency matters here.
Wegovy pricing in the private market isn't static. Novo Nordisk sets the list price at which they supply the medicine through the licensed UK supply chain, and private providers price above that to cover their own costs, clinical staff, prescriber time, pharmacy infrastructure, support services. When supply-chain list prices shift, private prices tend to follow, with some lag and variation between providers.
NICE recommended semaglutide (Wegovy) for NHS use under NICE technology appraisal TA875, but access through the NHS is restricted to specialist weight management services, and waiting lists can run long. For many people, private treatment is the practical alternative. That creates real demand, and where demand is high, prices tend to reflect it.
The broader context: how Wegovy's UK private price is structured depends on dose, provider and what's included. If you want a clearer sense of what Wegovy costs through a private provider, it helps to look at the full dose schedule rather than a single pen price. Providers at the lower end of the market often make savings somewhere, typically in the level of clinical oversight, aftercare access, or both. Worth thinking about.
At nume, one price covers everything: your consultation, prescription, the medicine itself, and next-working-day tracked delivery. No add-ons appear later. There's no subscription that renews quietly, and no auto-shipment, every repeat order is reviewed clinically before anything is dispensed.
We are deliberately not the cheapest option available. That's a considered choice. The clinical infrastructure behind every order (photo-ID and live weight verification, GP notification in line with GPhC guidance, and a named GPhC-registered prescriber reading your consultation the same day) costs something to run properly. We think it should.
A full picture of what private treatment costs month to month is on our treatment page. We don't print per-pen prices in body copy, not to obscure anything, but because what you'll pay depends on the clinical assessment. Wegovy's private UK pricing is explained in more detail there if you want to dig further into the numbers.
For most purchases, the cheapest option is fine. For a prescription-only injectable medicine with a documented counterfeit problem, it isn't. The MHRA has warned publicly (and acted on it) against fake weight-loss pens being sold online and through social media. Some of those counterfeits have contained insulin, causing serious harm. The MHRA's Yellow Card scheme lets you report suspect sellers; the GPhC pharmacy register lets you check whether a supplier is actually registered before you hand over your card details.
The right questions for a medicine like Wegovy: Is this pharmacy GPhC-registered? Is a qualified prescriber reviewing my case? Is the medicine sourced through the licensed UK supply chain? A price significantly below what legitimate providers charge is a reason to stop, not to click through. Checking whether a Wegovy price is realistic is a useful step before committing.
If you meet the eligibility criteria (broadly, a BMI of 30 or above, or 27 or above alongside a weight-related health condition) our prescribers can review your consultation the same day. See our weight-loss treatment overview or go straight to the free consultation to check your eligibility.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.